Author

Hongrong Zhang

University of MinnesotaORCID 0000-0001-5258-9046Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Guhan QianiD· 2 shared Ingunn M. StromnesiD· 2 shared Adam L. BurrackiD· 1 shared Alexander K. TsaiiD· 1 shared Ayaka Hulbert· 1 shared Beau R. WebberiD· 1 shared Branden S. MoriarityiD· 1 shared Christopher D. ZahmiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Guhan QianORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedOct 1, 2026

Abrogating TGFβ signaling in TCR-engineered T cells and enhancing antigen processing by tumor cells promotes sustained therapeutic activity in pancreatic ductal adenocarcinoma

Alexander K. Tsai, Meagan R. Rollins, Madeline A. Ellefson…·Ingunn M. Stromnes

This study shows that blocking TGFβ signaling in TCR-engineered T cells and enhancing antigen processing in tumor cells improves their therapeutic effectiveness against pancreatic ductal adenocarcinoma.

1 citation

mouseproteomics

𝕏 PostBluesky

BioengineeringbioRxivPreprintFeb 1, 2026

Engineering physically optimized T cells for increased sampling of complex tumor microenvironments

Hongrong Zhang, Zhongming Chen, Guhan Qian…·Paolo P. Provenzano

This study physically optimizes T cells to enhance their ability to sample and engage with pancreatic ductal adenocarcinoma tumor cells, improving therapeutic outcomes.

1 citation

humanproteomics

𝕏 PostBluesky